IFOSFAMIDE

IFOSFAMIDE was reported 21470 times

IFOSFAMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 T-CELL LYMPHOMA REFRACTORY 25 0.7143
1 PERIPHERAL BLOOD STEM CELL APHERESIS 10 0.6250
2 DESMOPLASTIC SMALL ROUND CELL TUMOUR 41 0.4713
3 RHABDOMYOSARCOMA RECURRENT 20 0.4651
4 RHABDOID TUMOUR 16 0.3077
5 OSTEOSARCOMA RECURRENT 18 0.3000
6 HAEMATOPOIETIC STEM CELL MOBILISATION 19 0.2969
7 MYELODYSPLASTIC SYNDROME WITH MULTILINEAGE DYSPLASIA 13 0.2549
8 PRIMITIVE NEUROECTODERMAL TUMOUR 11 0.2037
9 LEUKOERYTHROBLASTOSIS 19 0.1900
10 AMELOBLASTOMA 10 0.1887
11 BLOOD STEM CELL TRANSPLANT FAILURE 39 0.1822
12 AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANT 16 0.1798
13 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 163 0.1721
14 OVARIAN FAILURE 92 0.1720
15 B-CELL LYMPHOMA REFRACTORY 14 0.1573
16 SYNOVIAL SARCOMA 14 0.1474
17 PLEUROPARENCHYMAL FIBROELASTOSIS 15 0.1442
18 ENCEPHALITIS ENTEROVIRAL 16 0.1416
19 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 294 0.1332
20 MALIGNANT TRANSFORMATION 57 0.1269
21 FOLLICULAR LYMPHOMA RECURRENT 10 0.1250
22 OSTEOSARCOMA 48 0.1247
23 NEPHROBLASTOMA 14 0.1102
24 ADENOVIRUS REACTIVATION 15 0.1042
25 CONGENITAL APLASIA 31 0.0997
26 OSTEOSARCOMA METASTATIC 9 0.0947
27 SALIVARY GLAND CANCER 44 0.0892
28 B-CELL LYMPHOMA RECURRENT 46 0.0847
29 MENINGITIS TUBERCULOUS 47 0.0841
30 NEUROBLASTOMA RECURRENT 17 0.0837
31 BONE SARCOMA 16 0.0825
32 RHABDOMYOSARCOMA 15 0.0798
33 DELAYED PUBERTY 20 0.0787
34 FANCONI SYNDROME 109 0.0770
35 DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV 25 0.0762
36 MYELOID LEUKAEMIA 36 0.0719
37 ANAL INFLAMMATION 42 0.0657
38 ADENOVIRAL HEPATITIS 15 0.0638
39 LYMPHOMA TRANSFORMATION 22 0.0611
40 REFRACTORY CANCER 13 0.0610
41 PNEUMONIA ADENOVIRAL 12 0.0606
42 FOLLICULAR LYMPHOMA 53 0.0602
43 ASPERGILLUS INFECTION 395 0.0601
44 PARASITIC GASTROENTERITIS 11 0.0576
45 AZOOSPERMIA 22 0.0573
46 CELLULITIS GANGRENOUS 11 0.0558
47 SARS-COV-2 TEST NEGATIVE 35 0.0519
48 CHROMOSOME ANALYSIS ABNORMAL 13 0.0512
49 METASTASES TO MUSCLE 9 0.0497
50 SUBDURAL HYGROMA 15 0.0493
51 HIGH-GRADE B-CELL LYMPHOMA 9 0.0481
52 MARGINAL ZONE LYMPHOMA 10 0.0467
53 HEPATOSPLENIC T-CELL LYMPHOMA 17 0.0458
54 CYTOPENIA 556 0.0454
55 GRANULOCYTES ABNORMAL 9 0.0448
56 ANGIOCENTRIC LYMPHOMA 22 0.0447
57 METASTASES TO SPLEEN 18 0.0436
58 APLASIA 85 0.0434
59 SOFT TISSUE SARCOMA 15 0.0430
60 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 28 0.0427
61 METASTASES TO BREAST 14 0.0422
62 DIFFUSE LARGE B-CELL LYMPHOMA 325 0.0421
63 NEUROBLASTOMA 16 0.0418
64 FEBRILE NEUTROPENIA 2685 0.0404
65 AUTOIMMUNE NEUTROPENIA 11 0.0381
66 MYELODYSPLASTIC SYNDROME 547 0.0378
67 TUMOUR COMPRESSION 12 0.0377
68 RENAL TUBULAR DISORDER 105 0.0373
69 ENCEPHALITIS CYTOMEGALOVIRUS 16 0.0365
70 HAEMATOTOXICITY 346 0.0364
71 PREMATURE MENOPAUSE 33 0.0357
72 ENTEROBACTER SEPSIS 13 0.0351
73 VULVOVAGINITIS 10 0.0340
74 ACUTE MYELOID LEUKAEMIA 521 0.0334
75 CENTRAL HYPOTHYROIDISM 11 0.0332
76 NEUTROPENIC SEPSIS 231 0.0323
77 METASTASES TO THE MEDIASTINUM 13 0.0316
78 FEBRILE BONE MARROW APLASIA 131 0.0308
79 ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES 9 0.0307
80 IDIOPATHIC PNEUMONIA SYNDROME 9 0.0302
81 METASTASES TO HEART 9 0.0298
82 FANCONI SYNDROME ACQUIRED 52 0.0296
83 VENA CAVA THROMBOSIS 49 0.0295
84 SKIN TURGOR DECREASED 11 0.0284
85 MUCOSAL INFLAMMATION 742 0.0283
86 CENTRAL NERVOUS SYSTEM LYMPHOMA 39 0.0283
87 ACQUIRED DIAPHRAGMATIC EVENTRATION 10 0.0282
88 PLASMABLASTIC LYMPHOMA 10 0.0279
89 CYSTITIS HAEMORRHAGIC 112 0.0278
90 RECALL PHENOMENON 23 0.0275
91 NEUTROPENIC INFECTION 26 0.0272
92 NEOPLASM RECURRENCE 91 0.0268
93 SECOND PRIMARY MALIGNANCY 223 0.0268
94 ACETABULUM FRACTURE 10 0.0267
95 KLEBSIELLA SEPSIS 30 0.0266
96 ENCEPHALOPATHY 626 0.0255
97 MANTLE CELL LYMPHOMA RECURRENT 11 0.0253
98 VENOOCCLUSIVE DISEASE 62 0.0247
99 ANGIODYSPLASIA 9 0.0247
100 PSEUDOMONAL BACTERAEMIA 21 0.0246
101 BONE MARROW TOXICITY 29 0.0245
102 DRUG CLEARANCE DECREASED 31 0.0237
103 DYSPLASIA 28 0.0233
104 KLEBSIELLA BACTERAEMIA 22 0.0232
105 RENAL TUBULAR DYSFUNCTION 13 0.0230
106 NEPHROGENIC DIABETES INSIPIDUS 26 0.0225
107 CAECITIS 10 0.0222
108 OTOTOXICITY 41 0.0222
109 TUMOUR LYSIS SYNDROME 195 0.0221
110 METASTASES TO BONE MARROW 11 0.0220
111 HUMAN HERPESVIRUS 8 INFECTION 13 0.0213
112 GENE MUTATION 42 0.0212
113 SARCOMA 24 0.0212
114 BONE MARROW FAILURE 430 0.0211
115 MOTOR DEVELOPMENTAL DELAY 12 0.0208
116 SYSTEMIC CANDIDA 52 0.0207
117 RENAL TUBULAR INJURY 25 0.0206
118 PERIORBITAL CELLULITIS 11 0.0205
119 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED 12 0.0203
120 BODY HEIGHT BELOW NORMAL 13 0.0202
121 TOXIC ENCEPHALOPATHY 102 0.0201
122 TRACHEITIS 15 0.0197
123 VIRAL HAEMORRHAGIC CYSTITIS 14 0.0197
124 NEUROTOXICITY 344 0.0196
125 ABDOMINAL LYMPHADENOPATHY 17 0.0196
126 ANGIOSARCOMA 9 0.0195
127 ACUTE PROMYELOCYTIC LEUKAEMIA 20 0.0195
128 VASOGENIC CEREBRAL OEDEMA 14 0.0194
129 EAR MALFORMATION 9 0.0194
130 OVARIAN DISORDER 18 0.0192
131 ARACHNOIDITIS 13 0.0188
132 ESCHERICHIA BACTERAEMIA 44 0.0187
133 THERAPY PARTIAL RESPONDER 291 0.0186
134 KLEBSIELLA TEST POSITIVE 12 0.0184
135 EPSTEIN BARR VIRUS POSITIVE MUCOCUTANEOUS ULCER 9 0.0183
136 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 107 0.0180
137 OLIGOHYDRAMNIOS 60 0.0180
138 VENOOCCLUSIVE LIVER DISEASE 87 0.0176
139 DISEASE PROGRESSION 2070 0.0175
140 HEPATITIS E 27 0.0171
141 GRAFT COMPLICATION 10 0.0170
142 CYTOKINE RELEASE SYNDROME 341 0.0170
143 QUADRIPLEGIA 35 0.0170
144 ACUTE LYMPHOCYTIC LEUKAEMIA 48 0.0169
145 ENGRAFTMENT SYNDROME 10 0.0169
146 TRACHEOBRONCHITIS 13 0.0169
147 MYELOPATHY 32 0.0168
148 NEPHROPATHY TOXIC 189 0.0168
149 CARDIOTOXICITY 149 0.0167
150 SUPERFICIAL VEIN THROMBOSIS 14 0.0166
151 NEUTROPENIC COLITIS 34 0.0164
152 STEM CELL TRANSPLANT 41 0.0164
153 PNEUMOTHORAX SPONTANEOUS 11 0.0162
154 MYELOSUPPRESSION 579 0.0161
155 EPSTEIN-BARR VIRUS TEST POSITIVE 10 0.0158
156 METASTASES TO PERITONEUM 40 0.0158
157 SCEDOSPORIUM INFECTION 11 0.0156
158 PLATELET TRANSFUSION 20 0.0155
159 GASTROINTESTINAL TOXICITY 74 0.0154
160 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 11 0.0153
161 LEUKOENCEPHALOPATHY 56 0.0150
162 PSEUDOMONAL SEPSIS 26 0.0148
163 HEPATITIS B REACTIVATION 47 0.0148
164 BLOOD LACTATE DEHYDROGENASE ABNORMAL 10 0.0147
165 STREPTOCOCCAL BACTERAEMIA 16 0.0147
166 SYSTEMIC MYCOSIS 17 0.0146
167 PANCYTOPENIA 814 0.0146
168 BLOOD LACTATE DEHYDROGENASE INCREASED 226 0.0142
169 METASTASES TO MENINGES 32 0.0141
170 NEUTROPENIA 1905 0.0140
171 THROMBOCYTOPENIA 1564 0.0140
172 HYPOGAMMAGLOBULINAEMIA 91 0.0138
173 CYTOMEGALOVIRUS CHORIORETINITIS 27 0.0138
174 INTUSSUSCEPTION 13 0.0136
175 ENTEROCUTANEOUS FISTULA 12 0.0136
176 RESORPTION BONE INCREASED 11 0.0134
177 GASTRITIS HAEMORRHAGIC 20 0.0134
178 POST-ACUTE COVID-19 SYNDROME 16 0.0129
179 POSITRON EMISSION TOMOGRAM ABNORMAL 9 0.0129
180 PULMONARY VENO-OCCLUSIVE DISEASE 9 0.0129
181 PERIPHERAL MOTOR NEUROPATHY 18 0.0128
182 PERIPHERAL NERVE INJURY 11 0.0126
183 PYELOCALIECTASIS 12 0.0125
184 POSTICTAL STATE 13 0.0125
185 JC VIRUS INFECTION 20 0.0125
186 FOETAL GROWTH RESTRICTION 76 0.0125
187 SEPSIS NEONATAL 10 0.0123
188 BLOOD FIBRINOGEN DECREASED 14 0.0123
189 METASTASES TO LUNG 139 0.0120
190 DILATED CARDIOMYOPATHY 12 0.0119
191 BK VIRUS INFECTION 40 0.0118
192 B-CELL LYMPHOMA 40 0.0118
193 HEPATOSPLENOMEGALY 30 0.0117
194 HYPOPHOSPHATAEMIA 85 0.0115
195 TUMOUR NECROSIS 12 0.0114
196 PNEUMONIA CYTOMEGALOVIRAL 22 0.0113
197 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 108 0.0113
198 HYPERLEUKOCYTOSIS 10 0.0113
199 CANDIDA SEPSIS 10 0.0111
200 PNEUMONIA FUNGAL 44 0.0111
201 MYELITIS 17 0.0110
202 DEVELOPMENTAL HIP DYSPLASIA 9 0.0108
203 ADENOCARCINOMA GASTRIC 10 0.0108
204 NEOPLASM PROGRESSION 368 0.0106
205 BONE MARROW DEPRESSION 10 0.0102
206 FUNGAEMIA 16 0.0102
207 TUMOUR HAEMORRHAGE 29 0.0102
208 HYPOALBUMINAEMIA 79 0.0102
209 ENTEROCOCCAL INFECTION 49 0.0101
210 HYPOFIBRINOGENAEMIA 10 0.0101
211 KLEBSIELLA INFECTION 51 0.0101
212 PNEUMOCYSTIS JIROVECII INFECTION 12 0.0100
213 OROPHARYNGEAL CANDIDIASIS 9 0.0099
214 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 14 0.0099
215 BACTERIAL SEPSIS 32 0.0098
216 MENINGITIS BACTERIAL 14 0.0098
217 HISTIOCYTOSIS HAEMATOPHAGIC 29 0.0098
218 CYTOGENETIC ABNORMALITY 11 0.0097
219 DEMYELINATING POLYNEUROPATHY 10 0.0097
220 NOROVIRUS INFECTION 14 0.0097
221 LEUKOPENIA 485 0.0097
222 BLOOD CULTURE POSITIVE 29 0.0097
223 RENAL TUBULAR ACIDOSIS 21 0.0096
224 DIFFUSE ALVEOLAR DAMAGE 11 0.0096
225 DIABETES INSIPIDUS 23 0.0095
226 ENTEROBACTER INFECTION 16 0.0095
227 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 78 0.0094
228 POSTOPERATIVE WOUND COMPLICATION 12 0.0094
229 ABDOMINAL MASS 25 0.0093
230 STRONGYLOIDIASIS 15 0.0093
231 PERIPHERAL SENSORY NEUROPATHY 54 0.0092
232 HEARING IMPAIRED 55 0.0092
233 BRONCHOPULMONARY ASPERGILLOSIS 71 0.0091
234 PNEUMONIA PSEUDOMONAL 14 0.0091
235 BACTERAEMIA 108 0.0091
236 PACKED RED BLOOD CELL TRANSFUSION 12 0.0091
237 SYSTEMIC INFECTION 15 0.0090
238 GLYCOSURIA 12 0.0089
239 LYMPHOMA 136 0.0088
240 POLYNEUROPATHY 105 0.0088
241 VARICELLA ZOSTER VIRUS INFECTION 18 0.0087
242 ADENOVIRUS INFECTION 25 0.0086
243 PROCTALGIA 55 0.0085
244 METASTASIS 61 0.0085
245 PROCALCITONIN INCREASED 10 0.0085
246 MUCORMYCOSIS 22 0.0085
247 STREPTOCOCCAL SEPSIS 10 0.0084
248 RADIATION PNEUMONITIS 18 0.0084
249 SEPTIC SHOCK 362 0.0083
250 OSTEOLYSIS 17 0.0083
251 WHITE BLOOD CELL DISORDER 22 0.0082
252 ENTEROCOLITIS 47 0.0081
253 LYMPHOPENIA 115 0.0081
254 FOETAL DEATH 42 0.0081
255 GRANULOCYTE COUNT DECREASED 15 0.0081
256 OESOPHAGEAL CANDIDIASIS 32 0.0080
257 MENINGITIS CRYPTOCOCCAL 14 0.0080
258 PLATELET COUNT ABNORMAL 48 0.0079
259 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 40 0.0079
260 OSTEOPOROTIC FRACTURE 15 0.0078
261 HYPERBILIRUBINAEMIA 81 0.0078
262 GLOMERULONEPHRITIS 19 0.0078
263 MULTIPLE-DRUG RESISTANCE 24 0.0077
264 CYTOMEGALOVIRUS INFECTION REACTIVATION 34 0.0077
265 PNEUMONIA KLEBSIELLA 14 0.0076
266 LUNG OPACITY 20 0.0076
267 METASTASES TO LYMPH NODES 51 0.0075
268 NEUTROPHIL COUNT ABNORMAL 21 0.0074
269 PNEUMONIA PNEUMOCOCCAL 11 0.0074
270 ENCEPHALITIS VIRAL 9 0.0074
271 HAEMOGLOBIN ABNORMAL 47 0.0073
272 BLOOD ELECTROLYTES ABNORMAL 9 0.0073
273 SEPSIS 810 0.0073
274 ESCHERICHIA SEPSIS 21 0.0072
275 GRAFT VERSUS HOST DISEASE 52 0.0072
276 HYDRONEPHROSIS 54 0.0072
277 CYTOMEGALOVIRUS INFECTION 119 0.0072
278 CUTANEOUS T-CELL LYMPHOMA 9 0.0071
279 OSTEOMALACIA 11 0.0071
280 RECURRENT CANCER 29 0.0071
281 EROSIVE OESOPHAGITIS 12 0.0071
282 WHITE BLOOD CELL COUNT ABNORMAL 45 0.0070
283 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 15 0.0070
284 MALIGNANT NEOPLASM PROGRESSION 720 0.0070
285 LYMPHOCYTOSIS 15 0.0070
286 DEVICE RELATED SEPSIS 14 0.0069
287 BLADDER SPASM 13 0.0069
288 SMALL INTESTINAL PERFORATION 13 0.0069
289 KIDNEY FIBROSIS 12 0.0069
290 DISEASE RECURRENCE 329 0.0069
291 STAPHYLOCOCCAL BACTERAEMIA 30 0.0069
292 NON-HODGKIN'S LYMPHOMA 9 0.0069
293 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 19 0.0069
294 CLOSTRIDIAL INFECTION 23 0.0068
295 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 12 0.0068
296 IMMUNE THROMBOCYTOPENIC PURPURA 19 0.0067
297 ANAEMIA 1269 0.0066
298 BONE MARROW DISORDER 20 0.0066
299 CLOSTRIDIUM DIFFICILE COLITIS 70 0.0066
300 PARAINFLUENZAE VIRUS INFECTION 10 0.0066
301 SOFT TISSUE INFECTION 12 0.0066
302 ELECTROLYTE IMBALANCE 76 0.0065
303 PSEUDOMONAS INFECTION 56 0.0065
304 MALIGNANT PLEURAL EFFUSION 11 0.0065
305 PULMONARY TOXICITY 46 0.0065
306 CARDIOMYOPATHY 96 0.0065
307 HEPATOTOXICITY 143 0.0064
308 TUBULOINTERSTITIAL NEPHRITIS 119 0.0063
309 PAPILLARY THYROID CANCER 11 0.0063
310 HYPERTRIGLYCERIDAEMIA 37 0.0063
311 HERPES SIMPLEX 41 0.0063
312 ALOPECIA AREATA 11 0.0063
313 MULTIPLE ORGAN DYSFUNCTION SYNDROME 177 0.0062
314 HEPATIC LESION 27 0.0062
315 CACHEXIA 32 0.0062
316 SUSPECTED OFF LABEL USE 28 0.0062
317 AGRANULOCYTOSIS 113 0.0061
318 NEUROLOGICAL DECOMPENSATION 14 0.0060
319 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 16 0.0060
320 HEPATITIS B 36 0.0060
321 MANTLE CELL LYMPHOMA 9 0.0059
322 CARDIAC DYSFUNCTION 22 0.0059
323 ASPARTATE AMINOTRANSFERASE ABNORMAL 9 0.0059
324 ACUTE GRAFT VERSUS HOST DISEASE 27 0.0059
325 PARAPLEGIA 17 0.0059
326 PARESIS 13 0.0058
327 LEFT VENTRICULAR DYSFUNCTION 39 0.0058
328 LEFT VENTRICULAR FAILURE 20 0.0058
329 CAPILLARY LEAK SYNDROME 12 0.0058
330 PNEUMOTHORAX 92 0.0058
331 PNEUMOCYSTIS JIROVECII PNEUMONIA 58 0.0058
332 ACUTE RESPIRATORY DISTRESS SYNDROME 102 0.0058
333 CONGESTIVE CARDIOMYOPATHY 24 0.0058
334 HYPERTRANSAMINASAEMIA 40 0.0057
335 LYMPHADENOPATHY MEDIASTINAL 11 0.0057
336 NEUTROPHIL COUNT DECREASED 234 0.0057
337 STAPHYLOCOCCUS TEST POSITIVE 12 0.0057
338 METABOLIC DISORDER 33 0.0057
339 INFECTION 818 0.0056
340 THERAPY NON-RESPONDER 254 0.0056
341 AREFLEXIA 15 0.0056
342 BICYTOPENIA 11 0.0056
343 DEVICE RELATED INFECTION 86 0.0056
344 SPEECH DISORDER DEVELOPMENTAL 16 0.0056
345 CLOSTRIDIUM DIFFICILE INFECTION 121 0.0055
346 CHRONIC GRAFT VERSUS HOST DISEASE 20 0.0055
347 COVID-19 PNEUMONIA 65 0.0055
348 TETANY 10 0.0055
349 DEAFNESS NEUROSENSORY 18 0.0055
350 BODY TEMPERATURE ABNORMAL 10 0.0054
351 BRAIN HERNIATION 16 0.0054
352 METASTASES TO CENTRAL NERVOUS SYSTEM 69 0.0053
353 ESCHERICHIA INFECTION 44 0.0053
354 HEPATORENAL SYNDROME 9 0.0053
355 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 40 0.0053
356 CANDIDA INFECTION 89 0.0053
357 BLOOD DISORDER 42 0.0052
358 HYPERNATRAEMIA 26 0.0052
359 ALANINE AMINOTRANSFERASE ABNORMAL 11 0.0052
360 FOETAL DISTRESS SYNDROME 11 0.0052
361 HYPOPITUITARISM 9 0.0052
362 PYELONEPHRITIS ACUTE 10 0.0051
363 VASCULAR DEVICE INFECTION 23 0.0051
364 STAPHYLOCOCCAL SEPSIS 25 0.0051
365 HENOCH-SCHONLEIN PURPURA 11 0.0050
366 DRUG RESISTANCE 128 0.0050
367 PANNICULITIS 12 0.0050
368 LYMPHADENITIS 12 0.0050
369 PAPILLOEDEMA 22 0.0049
370 DIFFUSE ALOPECIA 9 0.0048
371 THROMBOTIC THROMBOCYTOPENIC PURPURA 17 0.0048
372 STOMATITIS 292 0.0048
373 SKIN TOXICITY 27 0.0048
374 METASTASES TO SPINE 16 0.0048
375 GROWTH RETARDATION 14 0.0048
376 GRANULOCYTOPENIA 27 0.0047
377 EJECTION FRACTION DECREASED 73 0.0047
378 EMBOLISM 39 0.0047
379 EPSTEIN-BARR VIRUS INFECTION 29 0.0046
380 METASTATIC NEOPLASM 20 0.0046
381 VENTRICULAR DYSFUNCTION 12 0.0046
382 AMYLASE INCREASED 17 0.0046
383 PULMONARY HAEMORRHAGE 36 0.0046
384 APLASTIC ANAEMIA 24 0.0046
385 PNEUMATOSIS INTESTINALIS 13 0.0046
386 CLOSTRIDIUM TEST POSITIVE 10 0.0045
387 ENTERITIS 29 0.0045
388 NEOPLASM 52 0.0045
389 HYPOKALAEMIA 207 0.0045
390 MENINGITIS ASEPTIC 20 0.0045
391 WOUND DEHISCENCE 15 0.0044
392 GUILLAIN-BARRE SYNDROME 21 0.0043
393 METABOLIC ENCEPHALOPATHY 13 0.0043
394 ASCITES 127 0.0043
395 HYPERCAPNIA 13 0.0043
396 NECROSIS 24 0.0043
397 BLOOD CREATINE INCREASED 19 0.0043
398 DILATATION VENTRICULAR 9 0.0043
399 CYTOMEGALOVIRUS VIRAEMIA 19 0.0043
400 ILEUS 53 0.0043
401 DYSAESTHESIA 13 0.0042
402 FIBROSIS 13 0.0042
403 URINARY TRACT OBSTRUCTION 10 0.0042
404 CEREBELLAR SYNDROME 9 0.0041
405 MYCOBACTERIUM AVIUM COMPLEX INFECTION 11 0.0041
406 LYMPHOPROLIFERATIVE DISORDER 12 0.0041
407 PNEUMOCYSTIS JIROVECI PNEUMONIA 9 0.0040
408 STAPHYLOCOCCAL INFECTION 133 0.0040
409 ESCHERICHIA URINARY TRACT INFECTION 17 0.0040
410 NORMOCHROMIC NORMOCYTIC ANAEMIA 12 0.0040
411 CANDIDIASIS 16 0.0040
412 SMALL INTESTINAL OBSTRUCTION 49 0.0040
413 LUNG INFILTRATION 35 0.0040
414 LUNG CONSOLIDATION 11 0.0039
415 LYMPHADENOPATHY 139 0.0039
416 UROSEPSIS 36 0.0039
417 THROMBOTIC MICROANGIOPATHY 38 0.0039
418 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 9 0.0039
419 SPINAL CORD COMPRESSION 15 0.0038
420 COAGULOPATHY 64 0.0038
421 RESPIRATORY ACIDOSIS 15 0.0038
422 METASTASES TO LIVER 67 0.0038
423 ORAL CANDIDIASIS 50 0.0038
424 ACIDOSIS 29 0.0038
425 ATRIAL FIBRILLATION 369 0.0038
426 RESPIRATORY FAILURE 276 0.0038
427 GASTROINTESTINAL NECROSIS 11 0.0038
428 AZOTAEMIA 15 0.0038
429 CARDIAC FAILURE ACUTE 25 0.0037
430 BACTERIAL INFECTION 70 0.0037
431 STUPOR 12 0.0037
432 HYPOMAGNESAEMIA 52 0.0037
433 CEREBRAL ISCHAEMIA 19 0.0037
434 PLATELET COUNT DECREASED 393 0.0037
435 HAEMATOLOGICAL INFECTION 9 0.0037
436 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 14 0.0037
437 SKIN NECROSIS 19 0.0037
438 SUBDURAL HAEMORRHAGE 10 0.0037
439 TRANSAMINASES INCREASED 81 0.0036
440 PRODUCT USE IN UNAPPROVED INDICATION 899 0.0036
441 RED CELL DISTRIBUTION WIDTH INCREASED 15 0.0036
442 RHINOVIRUS INFECTION 14 0.0036
443 MONOCYTE COUNT INCREASED 13 0.0036
444 HAEMODIALYSIS 30 0.0036
445 PLATELET DISORDER 9 0.0036
446 VENOUS THROMBOSIS 14 0.0036
447 HAEMORRHAGE 372 0.0036
448 ANAL ABSCESS 19 0.0035
449 ATELECTASIS 34 0.0035
450 MEAN CELL VOLUME INCREASED 9 0.0035
451 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 36 0.0035
452 AUTOIMMUNE HAEMOLYTIC ANAEMIA 12 0.0035
453 LEUKAEMIA 33 0.0035
454 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 9 0.0035
455 BLOOD CREATININE ABNORMAL 12 0.0035
456 DEAFNESS 90 0.0034
457 VENTRICULAR HYPOKINESIA 11 0.0034
458 IMMUNOSUPPRESSION 30 0.0034
459 LYMPHOCYTE COUNT DECREASED 60 0.0034
460 LIVER ABSCESS 11 0.0034
461 WHITE BLOOD CELL COUNT DECREASED 367 0.0034
462 PNEUMONITIS 92 0.0034
463 FIBRIN D DIMER INCREASED 12 0.0034
464 CHRONIC LYMPHOCYTIC LEUKAEMIA 16 0.0034
465 MENTAL STATUS CHANGES 93 0.0033
466 ATYPICAL PNEUMONIA 10 0.0033
467 DISSEMINATED INTRAVASCULAR COAGULATION 47 0.0033
468 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 183 0.0033
469 HEPATIC FAILURE 100 0.0033
470 MALNUTRITION 37 0.0033
471 MYELOFIBROSIS 10 0.0033
472 COLITIS 125 0.0033
473 PREMATURE BABY 99 0.0033
474 ABSCESS LIMB 14 0.0033
475 BLOOD PHOSPHORUS DECREASED 12 0.0033
476 HYPOCALCAEMIA 62 0.0033
477 LOW BIRTH WEIGHT BABY 26 0.0033
478 ACCIDENT 39 0.0033
479 C-REACTIVE PROTEIN INCREASED 118 0.0032
480 OFF LABEL USE 2835 0.0032
481 PLEURAL EFFUSION 197 0.0032
482 BRAIN DEATH 10 0.0032
483 PYELONEPHRITIS 28 0.0032
484 ORGANISING PNEUMONIA 16 0.0032
485 SMALL FOR DATES BABY 16 0.0032
486 OESOPHAGITIS 35 0.0032
487 DIVERTICULUM INTESTINAL 14 0.0032
488 PREMATURE LABOUR 18 0.0032
489 ELECTROENCEPHALOGRAM ABNORMAL 10 0.0032
490 HYPERCALCAEMIA 39 0.0032
491 DRUG TOXICITY 43 0.0032
492 PNEUMONIA VIRAL 10 0.0031
493 HAEMOTHORAX 9 0.0031
494 NEUROPATHY PERIPHERAL 295 0.0031
495 NERVOUS SYSTEM DISORDER 96 0.0031
496 HYPERPYREXIA 13 0.0031
497 RENAL IMPAIRMENT 257 0.0031
498 IMMUNE THROMBOCYTOPENIA 14 0.0031
499 ANGIOPATHY 17 0.0030
500 ACUTE KIDNEY INJURY 464 0.0030
501 INFLAMMATORY MARKER INCREASED 15 0.0030
502 MULTI-ORGAN FAILURE 52 0.0030
503 MIXED LIVER INJURY 9 0.0030
504 RESPIRATORY SYNCYTIAL VIRUS INFECTION 26 0.0030
505 NEUROLOGICAL SYMPTOM 17 0.0030
506 HAEMORRHOIDS 58 0.0030
507 CARDIAC TAMPONADE 14 0.0029
508 HEPATIC CYST 10 0.0029
509 BODY TEMPERATURE INCREASED 60 0.0029
510 PYREXIA 1016 0.0029
511 HYPERURICAEMIA 12 0.0029
512 CATHETER SITE INFECTION 11 0.0029
513 HAEMOLYTIC ANAEMIA 26 0.0029
514 OLIGURIA 18 0.0029
515 ALANINE AMINOTRANSFERASE INCREASED 178 0.0029
516 STILLBIRTH 14 0.0029
517 PROTEINURIA 55 0.0029
518 PREMATURE DELIVERY 46 0.0029
519 HYPERREFLEXIA 10 0.0029
520 URINE OUTPUT DECREASED 25 0.0029
521 ACUTE HEPATIC FAILURE 39 0.0029
522 THROMBOPHLEBITIS 10 0.0028
523 MYOCLONUS 34 0.0028
524 BLOOD CREATININE INCREASED 186 0.0028
525 PNEUMONIA BACTERIAL 26 0.0028
526 CARDIOPULMONARY FAILURE 11 0.0028
527 LOCALISED OEDEMA 13 0.0028
528 PROSTATOMEGALY 11 0.0028
529 TACHYPNOEA 38 0.0028
530 PORTAL VEIN THROMBOSIS 9 0.0028
531 HYPOPHAGIA 71 0.0028
532 MONOPLEGIA 12 0.0028
533 INTESTINAL PERFORATION 31 0.0028
534 THROMBOCYTOSIS 10 0.0027
535 HYPOVOLAEMIC SHOCK 13 0.0027
536 MYOSITIS 24 0.0027
537 RETINAL HAEMORRHAGE 19 0.0027
538 GENERALISED TONIC-CLONIC SEIZURE 44 0.0027
539 RENAL TUBULAR NECROSIS 26 0.0026
540 LUNG INFECTION 41 0.0026
541 HYPERVOLAEMIA 13 0.0026
542 DERMATITIS BULLOUS 19 0.0026
543 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 13 0.0026
544 FACIAL PARESIS 9 0.0025
545 TREATMENT FAILURE 210 0.0025
546 GASTRIC ULCER HAEMORRHAGE 14 0.0025
547 HEPATIC FUNCTION ABNORMAL 94 0.0025
548 PERICARDIAL EFFUSION 58 0.0025
549 HYPOXIA 88 0.0025
550 FAECAL INCONTINENCE 12 0.0025
551 HAEMODYNAMIC INSTABILITY 19 0.0025
552 PARTIAL SEIZURES 13 0.0025
553 STATUS EPILEPTICUS 28 0.0025
554 SPLENOMEGALY 29 0.0025
555 SINUS TACHYCARDIA 35 0.0025
556 APPENDICITIS 23 0.0025
557 ENCEPHALITIS 17 0.0025
558 ACUTE RESPIRATORY FAILURE 47 0.0024
559 LEUKOCYTOSIS 44 0.0024
560 HERPES VIRUS INFECTION 14 0.0024
561 HAEMATURIA 83 0.0024
562 TOXICITY TO VARIOUS AGENTS 403 0.0024
563 CHEMOTHERAPY 9 0.0024
564 RENAL FUNCTION TEST ABNORMAL 11 0.0024
565 DISORIENTATION 93 0.0023
566 CARDIAC FAILURE CHRONIC 10 0.0023
567 MOUTH ULCERATION 49 0.0023
568 SARCOIDOSIS 11 0.0023
569 MITRAL VALVE INCOMPETENCE 26 0.0023
570 HAEMOGLOBIN DECREASED 235 0.0023
571 PERONEAL NERVE PALSY 13 0.0023
572 CATATONIA 12 0.0023
573 GRAND MAL CONVULSION 21 0.0023
574 PURPURA 20 0.0023
575 MENINGITIS 15 0.0022
576 ASPARTATE AMINOTRANSFERASE INCREASED 119 0.0022
577 SEROTONIN SYNDROME 43 0.0022
578 POSTOPERATIVE WOUND INFECTION 15 0.0022
579 URINARY TRACT DISORDER 10 0.0022
580 HYDROCEPHALUS 12 0.0022
581 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 51 0.0022
582 RENAL FAILURE ACUTE 92 0.0022
583 GASTROINTESTINAL PERFORATION 9 0.0022
584 FUNGAL INFECTION 72 0.0022
585 SUBARACHNOID HAEMORRHAGE 22 0.0022
586 ARTHRITIS INFECTIVE 10 0.0022
587 PERFORMANCE STATUS DECREASED 10 0.0021
588 NEPHROPATHY 20 0.0021
589 METABOLIC ACIDOSIS 68 0.0021
590 ALTERED STATE OF CONSCIOUSNESS 46 0.0021
591 TONSILLITIS 11 0.0021
592 ATAXIA 25 0.0021
593 SHOCK HAEMORRHAGIC 17 0.0021
594 LIPASE INCREASED 16 0.0021
595 RENAL FAILURE 276 0.0021
596 VISUAL FIELD DEFECT 15 0.0021
597 NYSTAGMUS 11 0.0021
598 CIRCULATORY COLLAPSE 35 0.0021
599 ECCHYMOSIS 14 0.0020
600 ERYTHEMA MULTIFORME 19 0.0020
601 CARDIOGENIC SHOCK 29 0.0020
602 HAEMORRHAGE INTRACRANIAL 30 0.0020
603 POISONING 25 0.0020
604 HEPATOCELLULAR INJURY 28 0.0020
605 DISEASE COMPLICATION 9 0.0020
606 PULMONARY ALVEOLAR HAEMORRHAGE 11 0.0020
607 RESPIRATORY DISTRESS 54 0.0020
608 HYPONATRAEMIA 109 0.0019
609 MASS 27 0.0019
610 CARDIAC FAILURE 155 0.0019
611 TACHYCARDIA 171 0.0019
612 OSTEONECROSIS 63 0.0019
613 PETECHIAE 20 0.0019
614 HYPOTONIA 19 0.0019
615 BLOOD ALBUMIN DECREASED 15 0.0019
616 HEMIPARESIS 32 0.0019
617 METASTASES TO BONE 31 0.0019
618 BLOOD BILIRUBIN INCREASED 51 0.0019
619 CHOLECYSTITIS 22 0.0018
620 ODYNOPHAGIA 11 0.0018
621 PRODUCT PRESCRIBING ISSUE 40 0.0018
622 DEEP VEIN THROMBOSIS 119 0.0018
623 PULMONARY OEDEMA 82 0.0018
624 THYROID CANCER 22 0.0018
625 BLOOD ALKALINE PHOSPHATASE INCREASED 45 0.0018
626 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 128 0.0018
627 SKIN MASS 12 0.0018
628 LIVE BIRTH 15 0.0018
629 PRODUCT USE ISSUE 334 0.0018
630 PATHOLOGICAL FRACTURE 9 0.0018
631 DERMATITIS 37 0.0018
632 ABSCESS 28 0.0018
633 ANURIA 15 0.0017
634 BRAIN OEDEMA 22 0.0017
635 SHOCK 40 0.0017
636 WOUND INFECTION 19 0.0017
637 FAILURE TO THRIVE 9 0.0017
638 APHASIA 52 0.0017
639 PULMONARY MASS 25 0.0017
640 IMMUNODEFICIENCY 25 0.0017
641 NEUTROPHIL COUNT INCREASED 17 0.0017
642 GASTROINTESTINAL INFLAMMATION 13 0.0017
643 DRUG INTERACTION 262 0.0016
644 HEPATIC CYTOLYSIS 21 0.0016
645 HEPATITIS 42 0.0016
646 SKIN HYPERPIGMENTATION 14 0.0016
647 GENERALISED OEDEMA 20 0.0016
648 INTRACRANIAL PRESSURE INCREASED 9 0.0016
649 VOMITING 758 0.0016
650 CENTRAL NERVOUS SYSTEM LESION 22 0.0016
651 AMENORRHOEA 28 0.0016
652 ASPHYXIA 13 0.0016
653 HICCUPS 13 0.0016
654 GAMMA-GLUTAMYLTRANSFERASE INCREASED 35 0.0016
655 CHOLESTASIS 30 0.0016
656 C-REACTIVE PROTEIN ABNORMAL 10 0.0016
657 INCOHERENT 10 0.0015
658 HYPERGLYCAEMIA 56 0.0015
659 TRANSFUSION 16 0.0015
660 TOXIC EPIDERMAL NECROLYSIS 23 0.0015
661 CORONAVIRUS INFECTION 10 0.0015
662 CONFUSIONAL STATE 244 0.0015
663 CELLULITIS 76 0.0015
664 RESPIRATORY DISORDER 45 0.0015
665 HEPATITIS CHOLESTATIC 9 0.0015
666 BLOOD UREA INCREASED 25 0.0015
667 INGUINAL HERNIA 9 0.0015
668 ORAL PAIN 33 0.0015
669 INTERSTITIAL LUNG DISEASE 71 0.0015
670 DELIRIUM 50 0.0014
671 INTENTIONAL PRODUCT USE ISSUE 126 0.0014
672 THERAPEUTIC RESPONSE DECREASED 87 0.0014
673 RENAL FAILURE CHRONIC 11 0.0014
674 BLOOD POTASSIUM DECREASED 43 0.0014
675 PNEUMONIA 462 0.0014
676 RIGHT VENTRICULAR FAILURE 10 0.0014
677 ADRENAL INSUFFICIENCY 17 0.0014
678 PARALYSIS 20 0.0014
679 SUBDURAL HAEMATOMA 20 0.0014
680 NO THERAPEUTIC RESPONSE 17 0.0014
681 RASH MACULO-PAPULAR 31 0.0014
682 DIARRHOEA HAEMORRHAGIC 13 0.0014
683 LIVER INJURY 34 0.0014
684 RENAL CYST 11 0.0014
685 URINARY INCONTINENCE 41 0.0014
686 ATRIAL FLUTTER 11 0.0014
687 CAESAREAN SECTION 16 0.0014
688 COVID-19 241 0.0014
689 DYSGRAPHIA 9 0.0014
690 EPISTAXIS 101 0.0013
691 MATERNAL EXPOSURE DURING PREGNANCY 120 0.0013
692 PULMONARY HYPERTENSION 28 0.0013
693 POLYURIA 11 0.0013
694 CEREBRAL HAEMORRHAGE 48 0.0013
695 DEVELOPMENTAL DELAY 12 0.0013
696 HEPATOMEGALY 13 0.0013
697 OPTIC NEURITIS 12 0.0013
698 OSTEOPENIA 20 0.0013
699 NEURALGIA 32 0.0013
700 TROPONIN INCREASED 10 0.0013
701 HYPERTHERMIA 10 0.0013
702 GASTROENTERITIS 19 0.0013
703 NERVE COMPRESSION 12 0.0013
704 SEIZURE 150 0.0013
705 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 38 0.0013
706 CHILLS 152 0.0013
707 TOXIC SKIN ERUPTION 13 0.0013
708 MOTOR DYSFUNCTION 13 0.0013
709 INTESTINAL OBSTRUCTION 48 0.0013
710 HAEMATEMESIS 32 0.0013
711 DECREASED APPETITE 291 0.0013
712 HYPOTENSION 251 0.0012
713 FULL BLOOD COUNT DECREASED 25 0.0012
714 DRUG INEFFECTIVE 1619 0.0012
715 PLATELET COUNT INCREASED 16 0.0012
716 LOWER GASTROINTESTINAL HAEMORRHAGE 9 0.0012
717 MEDICAL DEVICE COMPLICATION 9 0.0012
718 NIGHT SWEATS 39 0.0012
719 PHARYNGITIS 15 0.0012
720 PERITONITIS 25 0.0012
721 PANCREATITIS ACUTE 27 0.0012
722 DIALYSIS 17 0.0012
723 ATRIAL SEPTAL DEFECT 10 0.0012
724 PULMONARY EMBOLISM 113 0.0012
725 UPPER GASTROINTESTINAL HAEMORRHAGE 20 0.0012
726 GASTROINTESTINAL HAEMORRHAGE 99 0.0012
727 HEPATIC ENCEPHALOPATHY 11 0.0012
728 COMA 56 0.0012
729 CONGENITAL ANOMALY 9 0.0012
730 UNRESPONSIVE TO STIMULI 30 0.0012
731 HAEMATOCRIT DECREASED 23 0.0012
732 JAUNDICE 31 0.0012
733 END STAGE RENAL DISEASE 21 0.0012
734 EPILEPSY 35 0.0011
735 BONE PAIN 67 0.0011
736 SUDDEN DEATH 12 0.0011
737 HYPOTHYROIDISM 36 0.0011
738 ANAPHYLACTIC SHOCK 29 0.0011
739 DYSPHAGIA 106 0.0011
740 VASCULITIS 13 0.0011
741 PRESYNCOPE 27 0.0011
742 CARDIAC ARREST 91 0.0011
743 DEHYDRATION 147 0.0011
744 ASPIRATION 12 0.0011
745 DRUG LEVEL INCREASED 18 0.0011
746 DRUG-INDUCED LIVER INJURY 34 0.0011
747 DRUG INTOLERANCE 104 0.0011
748 ORAL HERPES 21 0.0011
749 RESPIRATORY TRACT INFECTION 28 0.0011
750 ABDOMINAL PAIN 246 0.0011
751 SKIN LESION 29 0.0011
752 CARDIOMEGALY 13 0.0011
753 ILL-DEFINED DISORDER 64 0.0011
754 CONVULSION 60 0.0010
755 FOLLICULITIS 11 0.0010
756 MYOCARDITIS 12 0.0010
757 SUPRAVENTRICULAR TACHYCARDIA 10 0.0010
758 BLOOD MAGNESIUM DECREASED 9 0.0010
759 HALLUCINATION, VISUAL 22 0.0010
760 HALLUCINATION 78 0.0010
761 DECREASED ACTIVITY 11 0.0010
762 RED BLOOD CELL COUNT DECREASED 29 0.0010
763 BLOOD SODIUM DECREASED 19 0.0010
764 GASTROINTESTINAL DISORDER 89 0.0010
765 URINARY RETENTION 33 0.0010
766 DIARRHOEA 638 0.0010
767 GENERAL PHYSICAL HEALTH DETERIORATION 114 0.0010
768 COGNITIVE DISORDER 46 0.0010
769 DYSPNOEA EXERTIONAL 37 0.0010
770 SKIN INFECTION 11 0.0010
771 BLOOD CALCIUM DECREASED 11 0.0010
772 ANAPHYLACTIC REACTION 54 0.0010
773 SKIN ULCER 25 0.0010
774 HERPES ZOSTER 55 0.0010
775 GINGIVAL BLEEDING 13 0.0010
776 GASTRIC ULCER 18 0.0009
777 NAUSEA 749 0.0009
778 FULL BLOOD COUNT ABNORMAL 10 0.0009
779 AGITATION 69 0.0009
780 WHITE BLOOD CELL COUNT INCREASED 36 0.0009
781 BREAST PAIN 10 0.0009
782 TINNITUS 43 0.0009
783 MYDRIASIS 12 0.0009
784 DYSTONIA 18 0.0009
785 DEPRESSED LEVEL OF CONSCIOUSNESS 36 0.0009
786 RENAL INJURY 27 0.0009
787 MUSCULOSKELETAL CHEST PAIN 14 0.0009
788 CONSTIPATION 197 0.0009
789 OBSTRUCTIVE AIRWAYS DISORDER 10 0.0009
790 GLOMERULAR FILTRATION RATE DECREASED 11 0.0009
791 EMPHYSEMA 9 0.0009
792 RHABDOMYOLYSIS 37 0.0009
793 PULMONARY FIBROSIS 17 0.0009
794 OEDEMA 48 0.0009
795 ULCER 14 0.0009
796 SENSORY DISTURBANCE 14 0.0009
797 LIVER DISORDER 38 0.0009
798 INCONTINENCE 9 0.0009
799 INTERNATIONAL NORMALISED RATIO INCREASED 24 0.0008
800 PNEUMONIA ASPIRATION 21 0.0008
801 ISCHAEMIC STROKE 15 0.0008
802 GASTRITIS 22 0.0008
803 PULMONARY ARTERIAL HYPERTENSION 12 0.0008
804 PELVIC PAIN 15 0.0008
805 LIVER FUNCTION TEST ABNORMAL 24 0.0008
806 FLUID OVERLOAD 12 0.0008
807 FOETAL EXPOSURE DURING PREGNANCY 67 0.0008
808 THROMBOSIS 66 0.0008
809 CHRONIC KIDNEY DISEASE 62 0.0008
810 DYSURIA 30 0.0008
811 INFLAMMATION 42 0.0008
812 EATING DISORDER 17 0.0008
813 HAEMOPTYSIS 22 0.0008
814 ANOREXIA 10 0.0008
815 EXPOSURE DURING PREGNANCY 48 0.0008
816 FACE OEDEMA 13 0.0008
817 SYNCOPE 77 0.0008
818 CYANOSIS 12 0.0008
819 UPPER RESPIRATORY TRACT INFECTION 35 0.0008
820 CYSTITIS 24 0.0008
821 NEOPLASM MALIGNANT 50 0.0007
822 LETHARGY 43 0.0007
823 DRUG EFFECT INCOMPLETE 27 0.0007
824 LACTIC ACIDOSIS 24 0.0007
825 ARRHYTHMIA 35 0.0007
826 PANCREATITIS 39 0.0007
827 VIRAL INFECTION 24 0.0007
828 PSYCHOTIC DISORDER 21 0.0007
829 DELUSION 11 0.0007
830 MENTAL IMPAIRMENT 17 0.0007
831 ASTHENIA 263 0.0007
832 WEIGHT DECREASED 195 0.0007
833 INFUSION RELATED REACTION 46 0.0007
834 RENAL DISORDER 32 0.0007
835 MELAENA 15 0.0007
836 LUNG DISORDER 33 0.0007
837 ELECTROCARDIOGRAM QT PROLONGED 24 0.0007
838 DYSKINESIA 27 0.0007
839 DEATH 568 0.0007
840 DRUG EXPOSURE DURING PREGNANCY 22 0.0006
841 ALOPECIA 127 0.0006
842 HEPATIC ENZYME INCREASED 44 0.0006
843 FEEDING DISORDER 13 0.0006
844 ABDOMINAL PAIN LOWER 16 0.0006
845 STEVENS-JOHNSON SYNDROME 14 0.0006
846 CONDITION AGGRAVATED 189 0.0006
847 DIPLOPIA 16 0.0006
848 OSTEOMYELITIS 11 0.0006
849 VENTRICULAR TACHYCARDIA 10 0.0006
850 BLOOD COUNT ABNORMAL 9 0.0006
851 CONJUNCTIVITIS 11 0.0006
852 MOVEMENT DISORDER 19 0.0006
853 PALLOR 16 0.0006
854 OSTEOPOROSIS 24 0.0006
855 WRONG TECHNIQUE IN DRUG USAGE PROCESS 21 0.0006
856 ACUTE MYOCARDIAL INFARCTION 17 0.0006
857 OEDEMA PERIPHERAL 70 0.0006
858 CEREBRAL INFARCTION 14 0.0006
859 POST PROCEDURAL COMPLICATION 11 0.0006
860 SOMNOLENCE 115 0.0006
861 LOSS OF CONSCIOUSNESS 73 0.0006
862 BLINDNESS 23 0.0006
863 TRANSIENT ISCHAEMIC ATTACK 19 0.0006
864 BONE DISORDER 10 0.0005
865 BRADYCARDIA 29 0.0005
866 RASH ERYTHEMATOUS 26 0.0005
867 DISTURBANCE IN ATTENTION 29 0.0005
868 OXYGEN SATURATION DECREASED 30 0.0005
869 HYPERKALAEMIA 18 0.0005
870 COLD SWEAT 9 0.0005
871 ABNORMAL BEHAVIOUR 20 0.0005
872 PRODUCTIVE COUGH 24 0.0005
873 PREGNANCY 10 0.0005
874 CHOLELITHIASIS 16 0.0005
875 EXTRAPYRAMIDAL DISORDER 12 0.0005
876 DYSPNOEA 271 0.0005
877 HYPERTENSION 101 0.0005
878 BACK PAIN 110 0.0005
879 ERYTHEMA 97 0.0005
880 ADVERSE EVENT 42 0.0005
881 CHEST PAIN 83 0.0004
882 OROPHARYNGEAL PAIN 41 0.0004
883 NO ADVERSE EVENT 79 0.0004
884 MUSCLE TWITCHING 10 0.0004
885 HYPOGLYCAEMIA 21 0.0004
886 CARDIO-RESPIRATORY ARREST 18 0.0004
887 BLISTER 24 0.0004
888 FATIGUE 332 0.0004
889 SPEECH DISORDER 21 0.0004
890 CHROMATURIA 9 0.0004
891 COUGH 111 0.0004
892 CARDIAC DISORDER 37 0.0004
893 URINARY TRACT INFECTION 67 0.0004
894 BLOOD PRESSURE DECREASED 26 0.0004
895 CHEST DISCOMFORT 40 0.0004
896 DYSARTHRIA 14 0.0004
897 PARAESTHESIA 58 0.0004
898 VAGINAL HAEMORRHAGE 16 0.0004
899 IMPAIRED HEALING 12 0.0004
900 ABDOMINAL DISTENSION 38 0.0004
901 DIVERTICULITIS 10 0.0004
902 POLLAKIURIA 15 0.0004
903 RASH 156 0.0004
904 RESTLESSNESS 13 0.0004
905 ERECTILE DYSFUNCTION 9 0.0004
906 SKIN DISORDER 11 0.0003
907 RECTAL HAEMORRHAGE 14 0.0003
908 GYNAECOMASTIA 10 0.0003
909 PAIN 197 0.0003
910 DYSPEPSIA 31 0.0003
911 THERAPEUTIC RESPONSE UNEXPECTED 14 0.0003
912 PAIN IN EXTREMITY 91 0.0003
913 MUSCULAR WEAKNESS 35 0.0003
914 MOBILITY DECREASED 22 0.0003
915 LABORATORY TEST ABNORMAL 9 0.0003
916 CARDIAC FAILURE CONGESTIVE 24 0.0003
917 CONTRAINDICATED PRODUCT ADMINISTERED 9 0.0003
918 TYPE 2 DIABETES MELLITUS 10 0.0003
919 TREMOR 49 0.0003
920 CEREBROVASCULAR ACCIDENT 50 0.0003
921 EMOTIONAL DISORDER 9 0.0003
922 FEMUR FRACTURE 9 0.0003
923 INCORRECT ROUTE OF DRUG ADMINISTRATION 10 0.0003
924 HEADACHE 174 0.0003
925 MALAISE 120 0.0003
926 DYSPHONIA 16 0.0003
927 ECZEMA 14 0.0003
928 HYPERSENSITIVITY 49 0.0003
929 HEART RATE INCREASED 26 0.0003
930 DISCOMFORT 16 0.0003
931 AGGRESSION 13 0.0003
932 TREATMENT NONCOMPLIANCE 14 0.0003
933 FLUID RETENTION 13 0.0003
934 HYPOAESTHESIA 38 0.0003
935 ACCIDENTAL OVERDOSE 9 0.0002
936 SWELLING 23 0.0002
937 PROSTATE CANCER 19 0.0002
938 ARTHROPATHY 13 0.0002
939 MIGRAINE 22 0.0002
940 DIZZINESS 110 0.0002
941 HAEMATOCHEZIA 12 0.0002
942 AMNESIA 14 0.0002
943 SINUSITIS 22 0.0002
944 GAIT DISTURBANCE 41 0.0002
945 MYALGIA 36 0.0002
946 MEMORY IMPAIRMENT 29 0.0002
947 HYPOACUSIS 9 0.0002
948 MENTAL DISORDER 9 0.0002
949 ARTHRALGIA 85 0.0002
950 HYPERHIDROSIS 26 0.0002
951 PRURITUS 77 0.0002
952 IRRITABILITY 12 0.0002
953 UNEVALUABLE EVENT 15 0.0002
954 DEPRESSION 42 0.0002
955 BLOOD GLUCOSE INCREASED 33 0.0002
956 RHINORRHOEA 11 0.0002
957 BLOOD PRESSURE INCREASED 26 0.0002
958 SKIN EXFOLIATION 14 0.0002
959 ANXIETY 47 0.0002
960 OVERDOSE 35 0.0002
961 DYSGEUSIA 12 0.0002
962 PERIPHERAL SWELLING 24 0.0002
963 MYOCARDIAL INFARCTION 27 0.0002
964 INFLUENZA 17 0.0002
965 ABDOMINAL PAIN UPPER 31 0.0002
966 VISUAL IMPAIRMENT 18 0.0001
967 VISION BLURRED 19 0.0001
968 ADVERSE DRUG REACTION 12 0.0001
969 FALL 43 0.0001
970 FEELING ABNORMAL 29 0.0001
971 DIABETES MELLITUS 9 0.0001
972 FLUSHING 12 0.0001
973 WEIGHT INCREASED 26 0.0001
974 GASTROOESOPHAGEAL REFLUX DISEASE 9 0.0001
975 ABDOMINAL DISCOMFORT 18 0.0001
976 MUSCLE SPASMS 19 0.0001
977 PALPITATIONS 12 0.0001
978 URTICARIA 15 0.0001
979 HOSPITALISATION 13 0.0001
980 ASTHMA 9 0.0001
981 DRY SKIN 10 0.0001
982 NASOPHARYNGITIS 11 0.0001
983 DRUG DEPENDENCE 9 0.0001
984 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 10 0.0001
985 INSOMNIA 13 0.0000